Healthy Skepticism Library item: 14570

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Silverman E.
Senate Committees Probe Johnson & Johnson
Pharmalot 2008 Nov 4
http://www.pharmalot.com/2008/11/senate-committees-probe-johnson-johnson/

Full text:

The health care giant is being probed for two reasons – relationships with psychiatrists regarding an unnamed medication, and relationships with doctors and unspecified organizations concerning its Cypher stents, according to a filing with the Securities and Exchange Commission (see page 30).
On October 16, the US Senate Finance Committee and the Senate Special Committee on Aging sent a letter seeking info about the Cypher stent relationships. And the Finance Committee, separately, sent a letter on October 23 regarding info “on any payments or benefits to a number of specified psychiatrists associated with psychiatric professional associations or otherwise authorities in their field.” Which drug may be involved? Well, J&J sells the Risperdal and Invega antipsychotics, although a J&J spokesman says the health care giant has nothing more to say.